SCHEMBL19804779

SCHEMBL19804779

C=C(C)C(=O)OCCc1cc(-c2ccc3cc(-c4ccccc4)ccc3c2)c(CCOC(=O)C(=C)C)cc1OCCO

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 6/20 0.38
EGFR P00533 1/20 0.36
POLB P06746 1/20 0.35
APEX1 P27695 1/20 0.35
HTT P42858 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
RARA P10276 1/20 0.35
RARB P10826 1/20 0.35
RARG P13631 1/20 0.35
PTGER4 P35408 2/20 0.35
MTNR1A P48039 1/20 0.35
MTNR1B P49286 1/20 0.35
LTB4R Q15722 3/20 0.35
LTB4R2 Q9NPC1 3/20 0.35
CCNC P24863 2/20 0.33
CDK8 P49336 2/20 0.33
PTGER3 P43115 1/20 0.33
TARBP2 Q15633 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19804077 0.90 SLC6A9 (0.41) SLC6A9EGFRPOLBAPEX1HTT
SCHEMBL19804602 0.87 EGFR (0.35) SLC6A9EGFRPOLBAPEX1HTT
SCHEMBL19797152 0.87 MEN1 (0.37) RARARARBRARG
SCHEMBL19804239 0.86 LTB4R (0.41) RARARARBRARGLTB4RLTB4R2
SCHEMBL19804829 0.85 ESR1 (0.40) SLC6A9POLBAPEX1HTTTDP1
SCHEMBL19804140 0.85 SLC6A9 (0.44) SLC6A9EGFRPOLBAPEX1HTT
SCHEMBL19804369 0.85 SLC6A9 (0.44) SLC6A9EGFRPOLBAPEX1HTT
SCHEMBL19804819 0.84 ESR1 (0.39) SLC6A9POLBAPEX1HTTTDP1
SCHEMBL19804741 0.83 MTNR1A (0.39) SLC6A9EGFRPOLBAPEX1HTT
SCHEMBL19697386 0.83 RARA (0.44) SLC6A9EGFRRARARARBRARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, C1S, AP3D1 SLC6A9 2938/4885EGFR 3426/4885POLB 3105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.